Tenosynovial giant cell tumor (TGCT) is a group of rare, typically non-malignant tumors of the joints. TGCT tumors often develop from the lining of joints...
36 KB (2,854 words) - 07:09, 3 June 2024
Sarcoma (redirect from Reticulum cell sarcoma)
of the HMGA2 gene. Tenosynovial giant cell tumor (not a sarcoma, but a non-metastasizing and locally aggressive soft tissue tumor) frequently is associated...
37 KB (4,087 words) - 23:54, 14 August 2024
inhibitor drug for the treatment of adults with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations...
10 KB (679 words) - 23:14, 5 August 2024
cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS)". Journal...
22 KB (2,507 words) - 23:16, 25 July 2024
Synovial osteochondromatosis Plica syndrome villonodular synovitis Tenosynovial giant cell tumor Bursopathy Bursitis Olecranon Prepatellar Trochanteric Subacromial...
4 KB (333 words) - 16:11, 4 August 2024
Synovial osteochondromatosis Plica syndrome villonodular synovitis Tenosynovial giant cell tumor Bursopathy Bursitis Olecranon Prepatellar Trochanteric Subacromial...
9 KB (853 words) - 13:13, 5 August 2024
cell tumor Fibrous histiocytoma of tendon sheath Giant cell tumor of tendon sheath M9252/3 Malignant tenosynovial giant cell tumor Giant cell tumor of...
138 KB (9,870 words) - 22:47, 9 June 2024
with a manageable safety profile in patients with diffuse-type tenosynovial giant cell tumors (d-TGCT). Emactuzumab was originally developed by Roche/Genentech...
8 KB (697 words) - 19:21, 4 October 2023
in patients with tenosynovial giant cell tumor was started (NCT05804045). Following with pimicotinib for tenosynovial giant cell tumor treatment in phase...
6 KB (485 words) - 05:49, 19 July 2024
CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis". Human Cell. 36 (1): 456–467...
2 KB (171 words) - 01:39, 2 July 2024
was FDA-approved for treatment of diffuse-type tenosynovial giant cell tumors, a non-malignant tumor that develops from synovial tissue lining the joints...
44 KB (4,593 words) - 17:52, 18 April 2024
Genentech diffuse large B-cell lymphoma Pexidartinib Daiichi Sankyo tenosynovial giant cell tumor Entrectinib Genentech solid tumors that have a neurotrophic...
34 KB (180 words) - 22:09, 8 April 2024
2009). "Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types: diagnostic and histogenetic...
22 KB (2,433 words) - 05:09, 24 January 2024
"CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: A dose-escalation and dose-expansion...
96 KB (467 words) - 19:33, 6 August 2024